Abstract:Background: A new antibacterial compound powder of amoxicillin (AMO)/Radix Scutellaria extract (RSE) was developed, and its pharmacokinetics were determined in pigs following oral administration. Results: The MIC ranges of AMO against Escherichia coli, Staphylococcus aureus and Streptococcus were 1-8 μg/mL, 0.5-4 μg/mL and 0.5-64 μg/mL, respectively. The MIC ranges of RSE against E. coli, S. aureus, and Streptococcus were greater than 2.5 mg/mL, 0.156-2.5 mg/mL, and greater than 2.5 mg/mL, respectively. For S. aureus, the combined drug susceptibility test showed that AMO and RSE had an additive or synergistic effect. The results of compatibility test, the excipient screening test and the drug quality control test showed that the formulation had stable quality and uniform properties under the test conditions. Two studies were conducted to investigate the pharmacokinetics of the compound product in pigs. First, the pharmacokinetics of the AMO-RSE powder were compared with those of their respective single products. The results showed no significant change in the main pharmacokinetic parameters when either component was removed from the compound formulation; thus, AMO and RSE have no pharmacokinetic interaction in pigs. Second, pigs were orally administered three different doses of AMO-RSE powder. The Cmax and AUC increased proportionally with increasing p.o. dose; thus, the λz, t1/2λ, MRT, and Tmax were unchanged for the doses of 10, 20, and 30 mg/kg AMO and the doses of 5, 10, and 15 mg/kg BCL, showing that AMO/baicalin in AMO-RSE powder showed linear pharmacokinetic characteristics in pigs. Conclusions: The combined drug sensitivity test of AMO and RSE against S. aureus showed that the combination was additive or synergistic. Pharmacokinetic studies indicated that AMO and BCL do not interfere with each other in pigs when used in a compound formulation. The pharmacokinetic parameters remained unchanged regardless of the dose for p.o. administration, indicating linear pharmacokinetic properties over the tested dose range. The quality of the AMO-RSE powder was good and stable, providing a foundation for its clinical application in veterinary medicine. Further bioavailability, PK/PD and clinical trials are still needed to determine the final dosage regimen.

Double-coated Enrofloxacin Microparticles with Chitosan and Alginate: Preparation, Characterization and Taste-Masking Effect Study.

Preparation and Evaluation of an Enrofloxacin Self-Micro Emulsion for Veterinary Use

Effect of Replacing Antibiotics Using Multi-Enzyme Preparations on Production Performance and Antioxidant Activity in Piglets

pH‐driven entrapment of enrofloxacin in casein‐based nanoparticles for the enhancement of oral bioavailability

Effects of Increasing Concentrations of Enrofloxacin on Co-Digestion of Pig Manure and Corn Straw

Preparation, characterization, and pharmacokinetics of tilmicosin taste-masked formulation via hot-melt extrusion technology

Pharmacokinetics, Withdrawal Time, and Dietary Risk Assessment of Enrofloxacin and Its Metabolite Ciprofloxacin, and Sulfachloropyridazine‐trimethoprim in Taihe Black‐boned Silky Fowls

Intelligent-Responsive Enrofloxacin-Loaded Chitosan Oligosaccharide–Sodium Alginate Composite Core-Shell Nanogels for On-Demand Release in the Intestine

Preparation Process Optimization and Performance Characterization of Feed Plant Essential Oil Microcapsules

Dry Suspension Containing Coated Pellets with Ph-Dependent Drug Release Behavior for the Taste-masking of Azithromycin.

Quick and High-Throughput Quantification of Β-Agonists Residues in Animal-Derived Foods Using Enzymatic Probe Sonication Coupled with Automatic Solid-Phase Extraction

Permeability of Ehrlich ascites cells to folic acid, aminopterin, and amethopterin.

Simultaneous detection of enrofloxacin and florfenicol in animal-derived foods based on fluorescence quenching BELISA and a nanozyme catalytic strategy

Combining GC-MS/MS with a LLE-SPE sample pretreatment step to simultaneously analyse enrofloxacin and ofloxacin residues in chicken tissues and pork

Fluorescence quenching biomimetic ELISA based on quantum dots for enrofloxacin detection in animal-derived foods

Quantum dot-based biomimetic fluorescence immunoassays for enrofloxacin detection in animal-derived foods

Development of an amoxicillin-radix scutellaria extract formulation and evaluation of its pharmacokinetics in pigs

Monoclonal antibody for the development of specific immunoassays to detect Enrofloxacin in foods of animal origin

A Nanomaterials-based Biosensor for Rapid Detection of Enrofloxacin in Chicken Products

Enhancement of dissolution rate and oral bioavailability of poorly soluble drug florfenicol by using solid dispersion and effervescent disintegration technology

Taste-Masked Flucloxacillin Powder Part 2: Formulation Optimisation Using the Mixture Design Approach and Storage Stability